Affiliation:
1. Department of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, Changchun 130012, China
Abstract
It has been found that the development of some cancers can be attributed to obesity, which is associated with the excessive intake of lipids. Cancer cells undergo metabolic reprogramming, shifting from utilizing glucose to fatty acids (FAs) for energy. CD36, a lipid transporter, is highly expressed in certain kinds of cancer cells. High expressions of CD36 in tumor cells triggers FA uptake and lipid accumulation, promoting rapid tumor growth and initiating metastasis. Meanwhile, immune cells in the tumor microenvironment overexpress CD36 and undergo metabolic reprogramming. CD36-mediated FA uptake leads to lipid accumulation and has immunosuppressive effects. This paper reviews the types of FAs associated with cancer, high expressions of CD36 that promote cancer development and progression, effects of CD36 on different immune cells in the tumor microenvironment, and the current status of CD36 as a therapeutic target for the treatment of tumors with high CD36 expression.
Funder
Science and Technology Department of Jilin Province
Reference156 articles.
1. Lipid metabolism reprogramming and its potential targets in cancer;Cheng;Cancer Commun.,2018
2. The interaction of hepatic lipid and glucose metabolism in liver diseases;Bechmann;J. Hepatol.,2012
3. Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention;Butler;Adv. Drug Deliver Rev.,2020
4. Sun, C.Y., Zheng, Z.L., Chen, C.W., Lu, B.W., and Liu, D. (2022). Targeting Gut Microbiota With Natural Polysaccharides: Effective Interventions Against High-Fat Diet-Induced Metabolic Diseases. Front. Microbiol., 13.
5. European Code against Cancer 4th Edition: Obesity, body fatness and cancer;Anderson;Cancer Epidemiol.,2015